Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E P Cohen

Showing results (81-90 of 150) with videos related to

Pageof 15
Sort By:
The American Journal of the Medical Sciences|June 1, 1992
Mast cells and calcium in severe uremic itchingE P Cohen, T J Russell, J C Garancis
Archives of Physiology and Biochemistry|January 1, 1996
The role of nitric oxide in radiation nephropathyE P Cohen, B L Fish, J E Moulder
Bone Marrow Transplantation|April 1, 1997
Noncontinuous use of angiotensin converting enzyme inhibitors in the treatment of experimental bone marrow transplant nephropathyJ E Moulder, B L Fish, E P Cohen
The Journal of Laboratory and Clinical Medicine|September 11, 1999
Angiotensin II infusion exacerbates radiation nephropathyE P Cohen, B L Fish, J E Moulder
Advances in Experimental Medicine and Biology|January 5, 2002
Tumor immunity in mice immunized with fibroblasts transfected with tumor DNAE F de Zoeten, D Li, E P Cohen
Nephron|January 1, 1995
Bone marrow transplant nephropathy: radiation nephritis revisitedE P Cohen, C A Lawton, J E Moulder
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 8, 1998
Radiation nephropathy is treatable with an angiotensin converting enzyme inhibitor or an angiotensin II type-1 (AT1) receptor antagonistJ E Moulder, B L Fish, E P Cohen
Bone Marrow Transplantation|March 14, 2007
Significant increase in end-stage renal disease after hematopoietic stem cell transplantationE P Cohen, W R Drobyski, J E Moulder
Human Gene Therapy|October 10, 1997
Phase I evaluation of interleukin-2-transfected irradiated allogeneic melanoma for the treatment of metastatic melanoma: appendix 1: protocolT K Das Gupta, E P Cohen, J M Richards
Neurosurgery|March 3, 1998
Survival and toxicity of an allogeneic cytokine-secreting fibroblast vaccine in the central nervous systemW Griffitt, R P Glick, T Lichtor, et al.
Pageof 15

Showing results (81-90 of 150) with videos related to

Sort By:
Pageof 15
The American Journal of the Medical Sciences|June 1, 1992
Mast cells and calcium in severe uremic itchingE P Cohen, T J Russell, J C Garancis
Archives of Physiology and Biochemistry|January 1, 1996
The role of nitric oxide in radiation nephropathyE P Cohen, B L Fish, J E Moulder
Bone Marrow Transplantation|April 1, 1997
Noncontinuous use of angiotensin converting enzyme inhibitors in the treatment of experimental bone marrow transplant nephropathyJ E Moulder, B L Fish, E P Cohen
The Journal of Laboratory and Clinical Medicine|September 11, 1999
Angiotensin II infusion exacerbates radiation nephropathyE P Cohen, B L Fish, J E Moulder
Advances in Experimental Medicine and Biology|January 5, 2002
Tumor immunity in mice immunized with fibroblasts transfected with tumor DNAE F de Zoeten, D Li, E P Cohen
Nephron|January 1, 1995
Bone marrow transplant nephropathy: radiation nephritis revisitedE P Cohen, C A Lawton, J E Moulder
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 8, 1998
Radiation nephropathy is treatable with an angiotensin converting enzyme inhibitor or an angiotensin II type-1 (AT1) receptor antagonistJ E Moulder, B L Fish, E P Cohen
Bone Marrow Transplantation|March 14, 2007
Significant increase in end-stage renal disease after hematopoietic stem cell transplantationE P Cohen, W R Drobyski, J E Moulder
Human Gene Therapy|October 10, 1997
Phase I evaluation of interleukin-2-transfected irradiated allogeneic melanoma for the treatment of metastatic melanoma: appendix 1: protocolT K Das Gupta, E P Cohen, J M Richards
Neurosurgery|March 3, 1998
Survival and toxicity of an allogeneic cytokine-secreting fibroblast vaccine in the central nervous systemW Griffitt, R P Glick, T Lichtor, et al.
Pageof 15